Hashoo Foundation Medical Package at Chughtai Lab

Book at Chughtai Lab · Lahore, Pakistan

Book this test

Chughtai Lab logo

Chughtai Lab

20% off
Rs. 14,200Rs. 17,750

Hashoo Foundation Medical Package at Chughtai Lab

The Hashoo Foundation Medical Package at Chughtai Lab represents a landmark collaborative diagnostic initiative designed to deliver comprehensive, high-quality preventive healthcare screenings to patients, corporate partners, and welfare beneficiaries across Pakistan. In modern clinical practice, routine health screenings serve as the cornerstone of preventive medicine, enabling the early detection of physiological imbalances before they manifest as clinically overt diseases. This specialized medical panel integrates a carefully selected array of laboratory investigations, spanning hematology, metabolic biochemistry, renal assessment, and hepatic profiling. By evaluating these critical physiological systems simultaneously, the Hashoo Foundation Medical panel provides clinicians with a multi-dimensional view of a patient’s overall health status.

Chughtai Lab, as Pakistan’s premier diagnostic network, utilizes state-of-the-art automated laboratory technology, stringent quality control protocols, and expert pathological oversight to execute these tests with unmatched diagnostic precision. Whether utilized as a routine annual wellness check, an occupational health requirement, or a subsidized screening tool for underserved communities, this panel plays a vital role in reducing the burden of chronic diseases through timely, evidence-based intervention. The integration of advanced diagnostic modalities ensures that every specimen is processed with the highest fidelity, providing actionable clinical insights that empower patients and healthcare providers alike to make informed decisions regarding lifestyle, treatment, and long-term health management.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the clinical accuracy and reproducibility of the laboratory findings, patients must adhere to strict preparation guidelines. Because the Hashoo Foundation Medical panel includes metabolic markers such as fasting blood glucose and a complete lipid profile, the following preparation steps are essential:

  • Fasting Requirements: A strict fasting period of 10 to 12 hours is mandatory before sample collection. During this fasting window, patients must abstain from all food, caloric beverages, juices, tea, and coffee.
  • Hydration: Adequate hydration with plain water is highly encouraged, as dehydration can artificially elevate hematocrit levels and alter certain renal parameters.
  • Medication Management: Patients should consult their prescribing physician regarding the management of daily medications. Routine medications for chronic conditions like hypertension are typically continued, while insulin or oral hypoglycemic agents may need adjustment during the fasting state.
  • Avoid Substance Use: Strenuous physical exercise, alcohol consumption, and smoking should be avoided for at least 24 hours prior to sample collection, as these activities can transiently alter liver enzymes, lipid fractions, and metabolic rates.

During the Procedure

The diagnostic procedure for the Hashoo Foundation Medical panel is highly streamlined, safe, and minimally invasive, primarily involving a routine venipuncture and a clean-catch midstream urine collection. The process is executed with the utmost care to ensure patient comfort and sample integrity:

  • Patient Verification: Upon arrival at a Chughtai Lab facility, the patient’s identity is verified using double-identifier protocols to ensure absolute specimen traceability.
  • Venipuncture Process: The patient is comfortably seated, and a certified phlebotomist inspects the antecubital fossa to select a suitable vein. The site is thoroughly sanitized using a 70% isopropyl alcohol swab and allowed to air dry. A sterile tourniquet is applied briefly to facilitate venous engorgement.
  • Specimen Collection: Using a high-quality, sterile, single-use vacuum extraction needle system, the phlebotomist performs the venipuncture. Blood is collected into specific color-coded vacuum tubes: typically an EDTA tube for hematological analysis and a Serum Separator Tube (SST) for biochemical assays.
  • Post-Collection Care: Once collection is complete, the needle is safely withdrawn, and local pressure is applied to the puncture site with a sterile gauze pad, followed by the application of an adhesive bandage. The entire blood collection process takes less than five minutes and involves minimal discomfort.
  • Urine Collection: If a urine specimen is required, the patient is provided with a sterile, labeled container and instructed on the clean-catch midstream collection technique to prevent external contamination.

When is a Hashoo Foundation Medical Package Performed?

Routine Preventive Health and Wellness Screening

Preventive health screenings are essential for identifying asymptomatic physiological changes that precede chronic illnesses. Many debilitating conditions, such as early-stage chronic kidney disease, hepatic steatosis, and prediabetes, progress silently without presenting noticeable symptoms. By performing the Hashoo Foundation Medical panel annually or bi-annually, individuals can establish a baseline of their health metrics, allowing healthcare providers to detect subtle deviations early and implement lifestyle modifications or therapeutic interventions before irreversible organ damage occurs.

Evaluation of Metabolic and Cardiovascular Risk Factors

Cardiovascular diseases and metabolic syndrome remain leading causes of morbidity and mortality globally. This panel evaluates key lipid fractions, including total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides, alongside fasting plasma glucose. Physicians request this panel to stratify a patient’s cardiovascular risk, assess metabolic health, and identify insulin resistance or impaired glucose tolerance, which are critical precursors to type 2 diabetes and atherosclerotic cardiovascular disease.

Assessment of Renal and Hepatic Function

The liver and kidneys are the primary organs responsible for metabolism, detoxification, and waste excretion. Impairment in their function can lead to systemic toxicity and metabolic derangement. This panel evaluates vital biomarkers such as serum creatinine, blood urea nitrogen (BUN), and key hepatic enzymes (ALT, AST, ALP). Clinicians utilize these markers to screen for underlying hepatic disorders, such as non-alcoholic fatty liver disease (NAFLD) or viral hepatitis, and to monitor renal filtration efficiency, especially in patients with pre-existing risk factors like hypertension.

Investigation of Unexplained Fatigue and Systemic Symptoms

Persistent fatigue, lethargy, unexplained weight fluctuations, and generalized weakness are common clinical complaints that warrant thorough diagnostic investigation. The hematological component of the Hashoo Foundation Medical panel, specifically the Complete Blood Count (CBC), allows clinicians to evaluate red blood cell indices, hemoglobin concentration, and white blood cell dynamics. This helps rule out common causes of fatigue, such as iron deficiency anemia, megaloblastic anemia, or underlying chronic inflammatory and infectious processes.

Occupational Health and Welfare Program Monitoring

Organizations and welfare foundations, such as the Hashoo Foundation, frequently utilize this comprehensive medical panel to monitor the health status of their workforces, beneficiaries, or specific community cohorts. This proactive approach ensures that individuals in demanding work environments or vulnerable populations receive timely medical evaluations, helping organizations maintain occupational safety standards, implement targeted wellness programs, and provide necessary medical support to those in need.

What Does a Hashoo Foundation Medical Package Detect?

The Hashoo Foundation Medical panel is a comprehensive screening tool capable of detecting a wide range of physiological abnormalities. Clinically, the panel is designed to identify:

  • Microcytic hypochromic anemia (indicative of iron deficiency)
  • Macrocytic anemia (suggestive of Vitamin B12 or folate deficiency)
  • Leukocytosis (indicative of acute infection, inflammation, or physiological stress)
  • Leukopenia (suggestive of viral infections, bone marrow suppression, or autoimmune disorders)
  • Thrombocytopenia (increased risk of bleeding due to low platelet count)
  • Thrombocytosis (associated with chronic inflammation or myeloproliferative disorders)
  • Impaired fasting glucose (prediabetes)
  • Frank hyperglycemia (diagnostic of Diabetes Mellitus)
  • Hypoglycemia (abnormally low blood sugar levels)
  • Hypercholesterolemia (elevated total cholesterol, increasing cardiovascular risk)
  • Hypertriglyceridemia (elevated triglycerides, associated with metabolic syndrome and pancreatitis)
  • Low HDL cholesterol (reduced cardioprotective lipid levels)
  • Elevated LDL cholesterol (increased risk of atherogenesis)
  • Hyperuricemia (elevated uric acid, predisposing to gout or renal calculi)
  • Elevated serum creatinine (indicative of compromised glomerular filtration rate)
  • Elevated blood urea nitrogen (suggestive of renal impairment or dehydration)
  • Elevated Alanine Aminotransferase (ALT) (indicative of hepatocellular injury)
  • Elevated Aspartate Aminotransferase (AST) (suggestive of liver or muscle damage)
  • Elevated Alkaline Phosphatase (ALP) (indicative of cholestasis or bone turnover)
  • Hypoalbuminemia (suggestive of nutritional deficiency, chronic liver disease, or nephrotic syndrome)
  • Hyperbilirubinemia (indicative of hemolysis, hepatic dysfunction, or biliary obstruction)
  • Proteinuria (presence of protein in urine, indicating early diabetic nephropathy or renal disease)
  • Hematuria (presence of red blood cells in urine, suggesting infection, calculi, or neoplasm)
  • Pyuria (presence of white blood cells in urine, highly indicative of urinary tract infection)
  • Electrolyte imbalances (such as sodium or potassium deviations, affecting neuromuscular function)

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is widely recognized for its rapid turnaround times and highly accessible reporting infrastructure. For routine clinical chemistry and hematology parameters included in the Hashoo Foundation Medical panel, reports are typically finalized and verified by consultant pathologists within 12 to 24 hours of sample collection. Patients receive an automated SMS notification containing a secure link as soon as the reports are ready. Reports can be accessed, downloaded, and shared instantly through the My Chughtai mobile application or the official Chughtai Lab web portal. Additionally, patients can retrieve their diagnostic reports via Chughtai Lab’s dedicated WhatsApp service, ensuring maximum convenience and seamless integration with modern digital healthcare workflows.

Hashoo Foundation Medical Package Findings Overview

Structure / Parameter Evaluated Normal Findings Possible Abnormal Findings
Hemoglobin (Hb) Male: 13.5-17.5 g/dL, Female: 12.0-15.5 g/dL Low: Anemia (iron deficiency, chronic disease); High: Polycythemia, chronic hypoxia.
Fasting Blood Glucose 70-99 mg/dL High: Prediabetes (100-125 mg/dL), Diabetes Mellitus (>=126 mg/dL); Low: Hypoglycemia.
Total Cholesterol <200 mg/dL High: Hypercholesterolemia, increased risk of coronary artery disease.
Serum Creatinine Male: 0.6-1.2 mg/dL, Female: 0.5-1.1 mg/dL High: Acute kidney injury, chronic kidney disease; Low: Muscle wasting, severe malnutrition.
Alanine Aminotransferase (ALT) <45 U/L (varies by gender) High: Hepatocellular injury, fatty liver disease, viral hepatitis, drug-induced liver injury.
Blood Urea Nitrogen (BUN) 7-20 mg/dL High: Renal dysfunction, dehydration, high-protein diet, gastrointestinal bleeding.
Urine Routine Examination Clear, pale yellow, negative for protein, glucose, and nitrites; <5 WBCs/hpf Cloudy urine, positive protein (nephropathy), positive glucose (diabetes), elevated WBCs/bacteria (UTI).
Platelet Count 150,000 – 450,000 /uL Low: Thrombocytopenia (increased bleeding risk); High: Thrombocytosis (reactive or clonal).

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Hashoo Foundation Medical Package?

  • ISO 15189 certified diagnostic processes ensuring international standards of quality and accuracy.
  • State-of-the-art fully automated laboratory equipment minimizing human error.
  • Highly qualified team of consultant pathologists and experienced laboratory technologists.
  • Extensive network of collection centers across Pakistan for unmatched accessibility.
  • Convenient home sample collection services available in major cities.
  • User-friendly digital ecosystem including the My Chughtai App and WhatsApp report delivery.
  • Dedicated corporate and welfare helpdesks to facilitate smooth processing for partner organizations.
  • Commitment to ethical practices, patient safety, and compassionate healthcare delivery.

Frequently Asked Questions